mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |